Atlas Trials

EpiCor Clinical Study on Rapid Immune Modulating Effects

Clinical trial NCT05819424 · COMPLETED

Trial details

NCT number
NCT05819424
Sponsor
Cargill
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Immune Surveillance
Start date
2023-05-16
Primary completion
2023-11-16
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.